Walleye Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Sell
195,500
-169,000
-46% -$1.27M ﹤0.01% 1926
2025
Q4
$2.61M Buy
364,500
+212,200
+139% +$1.68M 0.01% 1643
2025
Q3
$1.63M Sell
152,300
-50,600
-25% -$497K 0.01% 1735
2025
Q2
$1.96M Buy
202,900
+81,200
+67% +$837K 0.01% 1532
2025
Q1
$1.81M Buy
121,700
+66,600
+121% +$1.02M 0.01% 1494
2024
Q4
$822K Sell
55,100
-18,400
-25% -$300K ﹤0.01% 2556
2024
Q3
$1.41M Sell
73,500
-100
-0.1% -$2.07K ﹤0.01% 2296
2024
Q2
$1.52M Sell
73,600
-29,100
-28% -$578K ﹤0.01% 2382
2024
Q1
$1.93M Buy
102,700
+13,100
+15% +$225K ﹤0.01% 2015
2023
Q4
$1.29M Buy
89,600
+73,900
+471% +$1.01M ﹤0.01% 2146
2023
Q3
$273K Sell
15,700
-3,500
-18% -$73K ﹤0.01% 3314
2023
Q2
$400K Buy
19,200
+8,300
+76% +$180K ﹤0.01% 2598
2023
Q1
$256K Buy
10,900
+600
+6% +$16.1K ﹤0.01% 2251
2022
Q4
$288K Sell
10,300
-1,200
-10% -$30.7K 0.01% 1819
2022
Q3
$269K Buy
+11,500
New +$347K 0.01% 1907

Other funds holding OGN

Walleye Capital's OGN Position: Q1 2026 in Review

Walleye Capital reduced its Organon & Co (OGN) stake by 74% in Q1 2026, selling an estimated $8.22M and leaving 393,125 shares worth $2.35M. The position accounts for 0.01% of the portfolio, ranked #1344.

Walleye Capital first reported a position in OGN in Q1 2023 and has held it in 11 quarters since. The position peaked at $10.7M in Q4 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Walleye Capital held 393,125 shares of Organon & Co worth $2.35M as of Q1 2026.
  • Walleye Capital sold 1,092,254 Organon & Co shares in Q1 2026, an estimated $8.22M.
  • Organon & Co made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1344 holding.
  • Walleye Capital first reported a position in Organon & Co in Q1 2023 and has held it in 11 quarters since.
  • Walleye Capital's Organon & Co position peaked at $10.7M in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.